slotkoers
Andere beurzen
|
||
- | - |
2023 | NeoPharm CO., LTD. Rapporteert winstresultaten voor het eerste kwartaal eindigend op 31 maart 2023 | CI |
Omzet 2024 * | 120 mld. 87,84 mln. 0 81,96 mln. | Omzet 2025 * | 145 mld. 106 mln. 0 99,04 mln. | Marktkapitalisatie | 205 mld. 150 mln. 0 140 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 23 mld. 16,84 mln. - 15,71 mln. | Nettowinst (verlies) 2025 * | 30 mld. 21,96 mln. - 20,49 mln. | EV/omzet 2024 * | 0,63 x |
Nettoliquiditeiten 2024 * | 128 mld. 93,99 mln. 0 87,7 mln. | Nettoliquiditeiten 2025 * | 152 mld. 112 mln. 0 104 mln. | EV/omzet 2025 * | 0,36 x |
K/w-verhouding 2024 * |
9,35
x | K/w-verhouding 2025 * |
7,13
x | Werknemers | - |
Dividendrendement 2024 * |
2,87% | Dividendrendement 2025 * |
2,87% | Vrij verhandelbaar | 56,96% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Yang-Soo Kim
CEO | Chief Executive Officer | 54 | 01-08-12 |
Yoon Kim
CTO | Chief Tech/Sci/R&D Officer | 59 | 01-07-00 |
Woo-Jae Lim
BRD | Director/Board Member | 45 | 25-03-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Yoon Kim
CTO | Chief Tech/Sci/R&D Officer | 59 | 01-07-00 |
Dong-Jin Choi
BRD | Director/Board Member | 64 | 21-03-19 |
Yang-Soo Kim
CEO | Chief Executive Officer | 54 | 01-08-12 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-3,10% | 251 mld. | |
+12,81% | 19,44 mld. | |
0,00% | 17,73 mld. | |
+0,38% | 11,04 mld. | |
-6,84% | 10,11 mld. | |
+16,90% | 7,51 mld. | |
+10,15% | 5,97 mld. | |
-1,01% | 4,42 mld. | |
-17,67% | 3,7 mld. |